Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001737287-24-000076
Filing Date
2024-12-02
Accepted
2024-12-02 14:11:47
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 2779
  Complete submission text file 0001737287-24-000076.txt   4183
Mailing Address 388 GREENWICH STREET, 17TH FLOOR NEW YORK NY 10013
Business Address
Humer Franz B (Reporting) CIK: 0001548072 (see all company filings)

Type: 144

Mailing Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 457-2700
Allogene Therapeutics, Inc. (Subject) CIK: 0001737287 (see all company filings)

EIN.: 823562771 | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-38693 | Film No.: 241518390
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)